Lyrа Launches 'Clinical-Grade' Chatbot Amid Growing Concern
Lyrа Health has launched a "clinical-grade" chatbot amid growing concern about mental health and artificial intelligence.
Lyrа Health announced its members will be able to talk about their mental health with a chatbot, making it the largest company to launch a generative artificial intelligence product as a part of ongoing therapy treatment.
With its chatbot, called Lyrа AI, the company joins a bevy of smaller mental health startups that have taken varying approaches to incorporating generative AI into their offerings.
Already there's evidence that widely available consumer bots such as ChatGPT are causing people to spiral into delusions, and bots have allegedly been involved in cases in which users harmed themselves.
This launch is further confirmation that companies are barreling ahead with using products powered by large language models in care even as there's concern from experts, regulators, and lawmakers that the tech can behave unpredictably.
Author's summary: Lyrа Health launches a clinical-grade chatbot amid concerns about AI in mental health.